Long-term efficacy and safety of enzalutamide monotherapy in hormone-naïve prostate cancer: 2 –year follow-up

Bertrand Tombal, Michael Borre, Per Rathenborg, Patrick Werbrouck, Hendrik van Poppel, Axel Heidenreich, Peter Iversen, Johan Braeckman, Jiri Heracek

OriginalsprogEngelsk
ArtikelnummerPD766
TidsskriftAnnals of oncology : official journal of the European Society for Medical Oncology / ESMO
Vol/bind25
Udgave nummer4
ISSN0923-7534
StatusUdgivet - 2014

Citationsformater